JP2024507948A5 - - Google Patents
Info
- Publication number
- JP2024507948A5 JP2024507948A5 JP2023552013A JP2023552013A JP2024507948A5 JP 2024507948 A5 JP2024507948 A5 JP 2024507948A5 JP 2023552013 A JP2023552013 A JP 2023552013A JP 2023552013 A JP2023552013 A JP 2023552013A JP 2024507948 A5 JP2024507948 A5 JP 2024507948A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- sequence shown
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163154166P | 2021-02-26 | 2021-02-26 | |
| US63/154,166 | 2021-02-26 | ||
| PCT/US2022/017945 WO2022183018A1 (en) | 2021-02-26 | 2022-02-25 | Protective antibodies against respiratory viral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507948A JP2024507948A (ja) | 2024-02-21 |
| JP2024507948A5 true JP2024507948A5 (https=) | 2025-03-05 |
Family
ID=83048466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552013A Pending JP2024507948A (ja) | 2021-02-26 | 2022-02-25 | 呼吸器ウイルス感染症に対する防御抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240150444A1 (https=) |
| EP (1) | EP4297780A4 (https=) |
| JP (1) | JP2024507948A (https=) |
| KR (1) | KR20230148418A (https=) |
| AU (1) | AU2022227761A1 (https=) |
| CA (1) | CA3209869A1 (https=) |
| WO (1) | WO2022183018A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| US20250304657A1 (en) * | 2022-08-29 | 2025-10-02 | Fred Hutchison Cancer Center | Antibodies with novel fc modification combinations that increase antibody function |
| WO2024077268A2 (en) * | 2022-10-07 | 2024-04-11 | Fred Hutchinson Cancer Center | Human metapneumovirus antibodies and uses thereof |
| WO2025165833A1 (en) * | 2024-01-29 | 2025-08-07 | Vanderbilt University | Hpiv3-neutralizing antibodies and methods of use thereof |
| CN119039429B (zh) * | 2024-08-27 | 2025-10-03 | 浙江大学 | 一种抗RBD单链抗体No.35及制备抗体偶联药物的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2504364T3 (pl) * | 2009-11-24 | 2017-12-29 | Medimmune Limited | Ukierunkowane środki wiążące przeciwko B7-H1 |
| CN104350069B (zh) * | 2012-03-20 | 2017-12-01 | 胡默波斯生物医学公司 | 中和rsv、mpv和pvm的抗体和其应用 |
| JO3519B1 (ar) * | 2013-01-25 | 2020-07-05 | Amgen Inc | تركيبات أجسام مضادة لأجل cdh19 و cd3 |
| CN110035771B (zh) * | 2016-10-21 | 2024-03-08 | 阿迪马布有限责任公司 | 抗呼吸道合胞病毒抗体及其产生和使用方法 |
| WO2019165019A1 (en) * | 2018-02-21 | 2019-08-29 | Vanderbilt University | Antibodies to human respiratory syncytial virus protein f pre-fusion conformation and methods of use therefor |
| US11066469B2 (en) * | 2019-06-12 | 2021-07-20 | Novartis Ag | Natriuretic peptide receptor 1 antibodies and methods of use |
-
2022
- 2022-02-25 JP JP2023552013A patent/JP2024507948A/ja active Pending
- 2022-02-25 KR KR1020237032306A patent/KR20230148418A/ko active Pending
- 2022-02-25 US US18/548,017 patent/US20240150444A1/en active Pending
- 2022-02-25 CA CA3209869A patent/CA3209869A1/en active Pending
- 2022-02-25 WO PCT/US2022/017945 patent/WO2022183018A1/en not_active Ceased
- 2022-02-25 EP EP22760503.7A patent/EP4297780A4/en active Pending
- 2022-02-25 AU AU2022227761A patent/AU2022227761A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024507948A5 (https=) | ||
| JP2012504955A5 (https=) | ||
| JP2023515271A5 (https=) | ||
| AU2016307967B2 (en) | Tissue factor pathway inhibitor antibodies and uses thereof | |
| JP2021521843A5 (https=) | ||
| JP2011528902A5 (https=) | ||
| RU2009129403A (ru) | Антитела, нейтрализующие цитомегаловирус человека, и их применение | |
| RU2012112829A (ru) | Анти-gitr-антитела | |
| JP2018535650A5 (https=) | ||
| JP2023523549A (ja) | ＳＡＲＳ－ＣｏＶ－２に対する抗体およびそれを使用する方法 | |
| JP2010534478A5 (https=) | ||
| RU2011105062A (ru) | Нейтрализующие антитела против вируса гриппа а и их использование | |
| JP2021533159A5 (https=) | ||
| JP2014519334A5 (https=) | ||
| JP2021534797A5 (https=) | ||
| US20250263467A1 (en) | Antibody therapies for sars-cov-2 infection | |
| JP2021531732A5 (https=) | ||
| JP2014501513A5 (https=) | ||
| JP2022543658A5 (https=) | ||
| JP2013521252A5 (https=) | ||
| JP2023542107A (ja) | ＳＡＲＳ－ＣｏＶ－２を標的とするシングルドメイン抗体 | |
| CN116194083A (zh) | 抗冠状病毒抗体和其用途 | |
| JP2015511216A5 (https=) | ||
| IL322846A (en) | Antibodies, antigen-binding fragments and methods of use | |
| JP2024518536A5 (https=) |